Table 1 Clinical characteristics
Characteristics | N (%) |
|---|---|
Karnosky performance score (KPS) | |
>70 | 74 (87.1) |
≤70 | 11 (12.9) |
Gender | |
Male | 78 (91.8) |
Female | 7 (8.2) |
Age | |
Median age | 50 (28-75) |
Alanine amino transferase ( ALT)(IU/I) | |
>40 | 26 (30.6) |
≤40 | 59 (69.4) |
Hemoglobin (HB)(g/L) | |
≥120 | 74 (87.1) |
<120 | 11 (12.9) |
Lactate dehydrogenase (LDH) (IU/l) | |
>245 | 54 (63.5) |
≤245 | 31 (36.5) |
Alkaline phosphatase (ALP) (IU/l) | |
>110 | 28 (32.9) |
≤110 | 57 (67.1) |
T stage (2002AJCC) | |
T1-2 | 35 (41.1) |
T3-4 | 50 (58.8) |
N stage (2002AJCC) | |
N0-1 | 21 (24.8) |
N2 | 40 (47.1) |
N3 | 24 (28.2) |
No. of metastatic lesion | |
≤3 | 35 (41.2) |
>3 | 50 (58.8) |
Size of metastatic lesions (cm) | |
≤3 | 53 (62.3) |
>3 | 32 (37.7) |
With extrahepatic metastases | |
Yes | 49 (57.6) |
No | 36 (42.4) |